Breast cancer, papilloma, pagets disease of the nipple Flashcards
What is the background for breast cancer?
● Breast cancer is the commonest cancer in the UK (15% of new cancer cases annually).
● There are approximately 56,000 new cases of breast cancer every year.
What are the pre-invasive types of
breast cancer?
- Ductal carcinoma in situ (DCIS).
● Neoplastic proliferation of epithelial cells - confined to duct without
invasion through basement membrane.
● Precursor to invasive breast cancer.
● Comedo and non-comedo subtypes. - Lobular carcinoma in situ (LCIS).
● Neoplastic proliferation of epithelial cells, confined to TDLU.
What are the invasive (penetration through basement membrane) types of breast cancer?
- Invasive ductal carcinoma (commonest - 75%).
● Neoplastic proliferation of epithelial cells that invades through the ductal
basement membrane. - Invasive lobular carcinoma
- Medullary carcinoma
● More prevalent in the younger population.
● Higher grade than IDC. - Many others - including mucinous, tubular, papillary, inflammatory etc.
What is the Nottingham criteria which we use to grade how bad a breast cancer is?
What is it scored on?
○ Gland formation
○ Nuclear atypia / pleomorphism
○ Mitosis counts (indicates rate of cellular reproduction)
● A higher grade carcinoma is one that is markedly different from normal breast tissue
and is considered poorly differentiated.
What is the aetiology and pathophysiology of breast cancer?
● Complex series of genetic mutations and deranged cellular signalling leads to generation
of malignant cells.
● Breast cancer can be linked to inherited genetic mutations such as BRCA1.
What is the 5 step process for malignant cells to metastasise?
- Invasion through basement membrane
- Intravasation (entry into circulation)
- Circulation
- Extravasation
- Colonisation
What are the commonest sites of breast cancer metastasis?
bones, liver, lungs and brain.
What are the RFs for breast cancer?
- Increasing age
- Female sex (100:1 F:M incidence)
- Family history
- Inherited genetic mutations e.g. BRCA1
- Endogenous oestrogen exposure:
a. Early menarche
b. Nulliparity / absence of breastfeeding
c. Late menopause - Exogenous oestrogen and progestin exposure:
a. Systemic hormonal HRT
b. Systemic hormonal contraception
Female (99% of breast cancers)
Increased oestrogen exposure (earlier onset of periods and later menopause)
More dense breast tissue (more glandular tissue)
Obesity
Smoking
Family history (first-degree relatives)
What are the signs and symptoms of breast cancer?
● Symptoms include: breast lump
● Signs include: nipple discharge, nipple retraction, skin changes e.g. peau d’orange,
axillary lymphadenopathy.
What are the metastatic features of breast cancer?
weight loss, bony pain, shortness of breath.
What are the different types of staging we use for breast cancer?
● TNM staging (tumour, node, metastasis) - see Cancer Research UK for full details.
● Alternative staging:
○ Stage 1A: <2cm, isolated to breast
○ Stage 1B: <2cm, minor axillary LN spread
○ Stage 2A: <2cm, spread to 1-3 ipsilateral LNs.
○ Stage 2B: 2 - 5cm, minor axillary nodal spread or 2 - 5cm with 1-3 ipsilateral
nodes or >5cm, no nodal spread
○ Stage 3A: 4-9 ipsilateral nodes or >5cm with 1-3 ipsilateral nodes
○ Stage 3B: spread to skin / chest wall
○ Stage 3C: >10 axillary nodes or supraclavicular spread or parasternal + axillary
spread
○ Stage 4: distant metastatic spread to organs.
What is the screening programme for breast cancer?
● NHS screening programme: 3-yearly mammogram for women aged 50-71.
What is the 2 week wait criteria for breast cancer?
○ Unexplained breast lump in a woman aged >30.
○ Unexplained axillary lump in a woman aged >30.
○ Unilateral nipple changes in a woman aged >50.
○ Skin changes suggestive of breast cancer, any age.
What is first line for breast cancer investigations for breast cancer?
breast imaging
○ >30 or highly suspicious for cancer: mammogram
○ <30: breast ultrasound
○ Plus: ultrasound of the axilla +/- needle biopsy
What is second line investigations for breast cancer?
biopsy
○ Fine needle aspiration and cytology
○ Plus: oestrogen / progesterone receptor testing, HER2 receptor testing.